← The Wire
PROKNasdaq
PROKIDNEY CORP.
Biological Products, (No Diagnostic Substances) · E9 · CIK 1850270
Develops autologous cell therapy to preserve kidney function in advanced chronic kidney disease patients
$337M
Market cap
$1.89
Last close
+3.3%
1D
+3.9%
5D
1.4M
Volume
Price · last 39 sessions+0.5%
May 4L $1.55 · H $1.96Jun 29
136
Total filings
May 29, 2026
Last filing
12/31
Fiscal year end
8-KShareholder VoteMay 29, 20268-KResults of Operations · Reg FD DisclosureMay 15, 202610-Q10-QMay 15, 2026SC 13D/ASC 13D/AApr 30, 2026DEFA14ADEFA14AApr 17, 2026DEF 14ADEF 14AApr 17, 20268-KResults of OperationsMar 18, 202610-K10-KMar 18, 20268-KReg FD Disclosure · Company UpdateFeb 2, 20268-KReg FD DisclosureJan 12, 20268-KResults of OperationsNov 10, 202510-Q10-QNov 10, 20258-KMaterial AgreementOct 17, 20258-KResults of OperationsAug 12, 202510-Q10-QAug 12, 20258-KReg FD Disclosure · Company UpdateJul 15, 20258-KMaterial Agreement · Agreement TerminatedJul 14, 2025424B5424B5Jul 14, 20258-KReg FD DisclosureJul 8, 20258-KReg FD DisclosureJul 1, 20258-KShareholder Vote · Reg FD DisclosureMay 30, 20258-KResults of OperationsMay 12, 202510-Q10-QMay 12, 2025S-4S-4Mar 31, 202510-K10-KMar 17, 20258-KResults of OperationsMar 17, 20258-KMaterial AgreementJan 21, 20258-KMaterial AgreementNov 22, 202410-Q10-QNov 12, 20248-KResults of OperationsNov 12, 2024SC 13GSC 13GNov 8, 2024SC 13GSC 13GOct 18, 20248-KReg FD Disclosure · Company UpdateSep 3, 202410-Q10-QAug 9, 20248-KResults of OperationsAug 9, 20248-KMaterial Agreement · Company UpdateJun 13, 2024424B5424B5Jun 13, 2024424B5424B5Jun 10, 20248-KReg FD Disclosure · Company UpdateJun 10, 20248-KShareholder VoteMay 31, 20248-KReg FD DisclosureMay 29, 202410-Q10-QMay 10, 20248-KResults of OperationsMay 10, 2024DEF 14ADEF 14AApr 26, 20248-KExecutive Change · Reg FD DisclosureMar 25, 20248-KResults of OperationsMar 22, 202410-K10-KMar 22, 20248-K/AExecutive ChangeMar 18, 20248-K/AExecutive ChangeMar 18, 20248-KExecutive ChangeFeb 12, 20248-KReg FD DisclosureJan 26, 20248-KMaterial AgreementJan 19, 2024424B5424B5Jan 19, 20248-K/AExecutive ChangeDec 5, 20238-KExecutive ChangeNov 30, 20238-KReg FD DisclosureNov 20, 202310-Q10-QNov 14, 20238-KResults of OperationsNov 14, 20238-KExecutive Change · Reg FD DisclosureNov 13, 2023SC 13DSC 13DNov 2, 20238-KReg FD DisclosureSep 11, 20238-KResults of OperationsAug 10, 202310-Q10-QAug 10, 20238-KCompany UpdateJul 18, 20238-KShareholder VoteJun 30, 20238-KMaterial AgreementJun 16, 2023DEF 14ADEF 14AMay 26, 20238-KResults of OperationsMay 11, 202310-Q10-QMay 11, 202310-K/A10-K/AApr 27, 20238-KResults of OperationsMar 28, 202310-K10-KMar 28, 20238-KCompany UpdateMar 6, 20238-KCompany UpdateFeb 6, 20238-KExecutive ChangeJan 19, 20238-KCompany UpdateJan 10, 20238-KReg FD DisclosureJan 10, 20238-KExecutive ChangeDec 6, 20228-KResults of OperationsNov 14, 202210-Q10-QNov 14, 2022
Insider Activity
In the 90 days to Nov 13, 2025: 1 sold $1.9M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 13, 2025 | Pereira Brian JgDirector | Sell | 447,803 | $2.37 | $1.1M |
| Nov 13, 2025 | Pereira Brian JgDirector | Sell | 54,333 | $2.37 | $129K |
| Nov 12, 2025 | Pereira Brian JgDirector | Sell | 227,431 | $2.72 | $619K |
| Nov 12, 2025 | Pereira Brian JgDirector | Sell | 27,595 | $2.72 | $75K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance